Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

A new cause for CA19.9 elevation: heavy tea consumption.

Howaizi M, Abboura M, Krespine C, Sbai-Idrissi MS, Marty O, Djabbari-Sobhani M.

Gut. 2003 Jun;52(6):913-4. No abstract available.

2.

[Extraordinary high elevation of serum CA19-9 levels in an apparently healthy subject].

Kaneko Y, Shibata Y, Nakamura H, Kuroda M, Nakazima T, Kasakura S.

Rinsho Byori. 1999 Oct;47(10):943-8. Japanese.

PMID:
10590668
3.

Mirizzi syndrome complicating an anomalous biliary tract: a novel cause of a hugely elevated CA19-9.

Robertson AG, Davidson BR.

Eur J Gastroenterol Hepatol. 2007 Feb;19(2):167-9.

PMID:
17273004
4.

[Usefulness of preoperative assay CEA and CA 19-9 in colorectal cancer patients].

Grotowski M, Maruszyński M, Piechota W.

Pol Merkur Lekarski. 2001 Dec;11(66):476-9. Polish.

PMID:
11899841
5.

Elevation of CA 19-9 in giant hydronephrosis induced by a renal calculus.

Meyer A, Kausch I, Krüger S, Fetscher S, Böhle A, Jocham D.

Urology. 2004 Feb;63(2):381-2.

PMID:
14972505
6.

[A case of urachal carcinoma associated with elevated levels of CA19-9].

Koyama I, Yamazaki Y, Nakamura R, Yago R, Nakamura M, Kobayashi H, Uchida Y, Ichikawa Y, Toma H.

Nihon Hinyokika Gakkai Zasshi. 1995 Oct;86(10):1587-90. Japanese.

7.

[Increased CA-19-9 caused by a splenic cyst: a rare differential diagnosis].

Decker D, Bollmann R, Hirner A, Stratmann H.

Zentralbl Chir. 1998;123(7):855-7. German.

PMID:
9746988
8.

[A resected case of intralobar pulmonary sequestration with increased serum tumor markers, CA19-9, CA125 and NCC-ST-439].

Nakamura H, Katsumi T, Nagata S, Saito M, Konaka C, Kato H.

Nihon Kyobu Shikkan Gakkai Zasshi. 1997 Dec;35(12):1425-29. Japanese.

PMID:
9567093
9.

Value of serum carbohydrate antigen 19-9 for predicting extrahepatic metastasis in patients with liver metastasis from colorectal carcinoma.

Sasaki A, Kawano K, Inomata M, Shibata K, Matsumoto T, Kitano S.

Hepatogastroenterology. 2005 Nov-Dec;52(66):1814-9.

PMID:
16334783
10.

[CA19-9].

Odagiri E.

Nihon Rinsho. 1999 Dec;57 Suppl:459-61. Review. Japanese. No abstract available.

PMID:
10778164
11.

[A case of CA19-9 producing transitional cell carcinoma of the ureter].

Yamamoto H, Ueda Y, Maruyama T, Kondou N, Nojima M, Takiuchi H, Mori Y, Shima H, Kubota A.

Hinyokika Kiyo. 2003 Sep;49(9):543-5. Japanese.

12.

[Renal cell carcinoma presenting high serum level of CA19-9 due to hydronephrosis: a case report].

Funahashi Y, Kamihira O, Hagikura S, Kasugai S, Kimura K, Fukatsu A, Matsuura O.

Nihon Hinyokika Gakkai Zasshi. 2008 Jan;99(1):39-42. Japanese.

13.

The role of serum and gastric juice levels of carcinoembryonic antigen, CA19.9 and CA72.4 in patients with gastric cancer.

Tocchi A, Costa G, Lepre L, Liotta G, Mazzoni G, Cianetti A, Vannini P.

J Cancer Res Clin Oncol. 1998;124(8):450-5.

PMID:
9750022
14.
15.

CA19-9 as a predictor of recurrence in patients with colorectal cancer.

Nakayama T, Watanabe M, Teramoto T, Kitajima M.

J Surg Oncol. 1997 Dec;66(4):238-43.

PMID:
9425326
16.

[A case of jejunal carcinoma presenting high level or serum CA19-9].

Kohzu T, Ikeda M, Shiratori K, Nemoto Y, Toki F, Hayashi N, Ueno E, Inoue Y, Yoshida K, Nakamura T, Suzuki M, Takasaki K.

Nihon Shokakibyo Gakkai Zasshi. 1998 Jul;95(7):781-5. Review. Japanese. No abstract available.

PMID:
9721520
17.

The clinical efficacy of CA 72-4 as serum marker for gastric cancer in comparison with CA19-9 and CEA.

Kodama I, Koufuji K, Kawabata S, Tetsu S, Tsuji Y, Takeda J, Kakegawa T.

Int Surg. 1995 Jan-Mar;80(1):45-8.

PMID:
7657491
18.

[Primary adenocarcinoma of the tunica vaginalis testis expressing CA19-9 antigen].

Muraki J, Hashimoto S, Morita T, Kobayashi Y, Nakamura S, Tokue A.

Nihon Hinyokika Gakkai Zasshi. 1995 Aug;86(8):1398-401. Japanese.

19.

CA19-9: the Italian experience.

Gullo L.

Pancreas. 1994 Nov;9(6):717-9. Review.

PMID:
7846014
20.

The clinical value of serum CEA, CA19-9, and CA242 in the diagnosis and prognosis of pancreatic cancer.

Ni XG, Bai XF, Mao YL, Shao YF, Wu JX, Shan Y, Wang CF, Wang J, Tian YT, Liu Q, Xu DK, Zhao P.

Eur J Surg Oncol. 2005 Mar;31(2):164-9.

PMID:
15698733

Supplemental Content

Support Center